About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 196 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 196 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-160 of 196 trials

CompletedAn Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaThis study will evaluate the safety, tolerability, and pharmacokinetics (PK) of various doses and dosing intervals of aripiprazole lauroxil.NCT02320032·Little Rock, Arkansas and 15 others CompletedA Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderThe purpose of this study is to evaluate the effectiveness and safety of flexible-doses paliperidone ER (3 to 12 mg as needed) compared with placebo over 3 weeks in patients with…NCT00309699·Cerritos, California and 46 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedOlanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaThis study is to determine the efficacy (how well the drug works), safety, and any side effects of olanzapine compared to placebo in the treatment of schizophrenia in adolescents.NCT00051298·Little Rock, Arkansas and 24 others

TerminatedExtension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaTo evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophreniaNCT03121586·Phoenix, Arizona and 160 others

RecruitingBiomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesThe Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia…NCT06740383·Hartford, Connecticut and 5 others

RecruitingA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)The purpose of this study is to evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents.NCT07288567·Anaheim, California and 36 others

CompletedTargeted Cognitive Training in Clinical High Risk (CHR) for PsychosisThis project is a randomized-controlled trial to test the efficacy of computer-based targeted cognitive training (TCT) versus a placebo intervention of commercial computer games…NCT02404194·Chicago, Illinois

CompletedA Comparator Study of LY2140023 Versus Placebo in Schizophrenia PatientsAn inpatient/outpatient study to see if LY2140023 is better than placebo in acutely ill patients with schizophrenia.NCT01086748·Escondido, California and 27 others

CompletedAn Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)This is a Phase 3, multicenter, 53-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in subjects with…NCT04659174·Bentonville, Arkansas and 43 others

CompletedAripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.A Multicenter, Double-blind 16 Week Study on the augmentation of atypical antipsychotic with Aripiprazole in patients with Schizophrenia with inadequate response to antipsychotic…NCT00325689·Little Rock, Arkansas and 47 others

CompletedQuetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With SchizophreniaThe purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate (SEROQUEL) compared with placebo in the treatment of adolescent patients with schizophrenia.NCT00090324·Dothan, Alabama and 41 others

CompletedEfficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaThe objective of this study is to explore the neurocognitive efficacy of Sertindole versus comparator in patients with schizophrenia using the MCCB.NCT00654706·Garden Grove, California and 25 others

TerminatedA Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaThe primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.NCT05443724·Phoenix, Arizona and 84 others

CompletedEfficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderThe purposes of this study are to assess the efficacy, safety, and side effects among doses approved by the Food and Drug Administration and higher (not FDA approved) doses of…NCT00100776·Anaheim, California and 32 others

CompletedA Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese patients with…NCT04524403·Bentonville, Arkansas and 39 others

CompletedA Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With SchizophreniaThis is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose…NCT07191483·Little Rock, Arkansas and 14 others

Completed15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedThe study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 15 months, in…NCT01157351·Bullhead City, Arizona and 55 others

TerminatedA Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX StudyThis study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013).NCT05211947·Anaheim, California and 302 others

CompletedTreatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia…NCT00043849·Birmingham, Alabama and 20 others

RecruitingRandomized Withdrawal Study in Patients With SchizophreniaThe purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in…NCT06961968·Rogers, Arkansas and 21 others

PreviousPage 8 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia